nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivacaftor—P-Glycoprotein Inhibitors—Cyclosporine—psoriasis	0.355	0.521	CiPCiCtD
Ivacaftor—Cytochrome P450 3A4 Inhibitors—Cyclosporine—psoriasis	0.326	0.479	CiPCiCtD
Ivacaftor—ALB—Acitretin—psoriasis	0.0416	0.192	CbGbCtD
Ivacaftor—CFTR—sweat gland—psoriasis	0.0244	0.5	CbGeAlD
Ivacaftor—CFTR—sweat—psoriasis	0.0205	0.419	CbGeAlD
Ivacaftor—ALB—Mycophenolate mofetil—psoriasis	0.0195	0.0899	CbGbCtD
Ivacaftor—ALB—Prednisone—psoriasis	0.0156	0.0719	CbGbCtD
Ivacaftor—CYP3A4—Calcitriol—psoriasis	0.0137	0.0631	CbGbCtD
Ivacaftor—CYP3A4—Methoxsalen—psoriasis	0.0106	0.0491	CbGbCtD
Ivacaftor—ABCB1—Mycophenolate mofetil—psoriasis	0.0102	0.047	CbGbCtD
Ivacaftor—ABCB1—Betamethasone—psoriasis	0.00875	0.0404	CbGbCtD
Ivacaftor—ABCB1—Prednisolone—psoriasis	0.00863	0.0398	CbGbCtD
Ivacaftor—ABCB1—Hydrocortisone—psoriasis	0.00818	0.0377	CbGbCtD
Ivacaftor—ABCB1—Prednisone—psoriasis	0.00815	0.0376	CbGbCtD
Ivacaftor—ALB—Methotrexate—psoriasis	0.00782	0.0361	CbGbCtD
Ivacaftor—ABCB1—Cyclosporine—psoriasis	0.00773	0.0356	CbGbCtD
Ivacaftor—CYP3A4—Cholecalciferol—psoriasis	0.00704	0.0325	CbGbCtD
Ivacaftor—CYP3A4—Triamcinolone—psoriasis	0.00611	0.0282	CbGbCtD
Ivacaftor—CYP3A4—Mycophenolate mofetil—psoriasis	0.00611	0.0282	CbGbCtD
Ivacaftor—CYP3A4—Betamethasone—psoriasis	0.00524	0.0242	CbGbCtD
Ivacaftor—CYP3A4—Prednisolone—psoriasis	0.00517	0.0239	CbGbCtD
Ivacaftor—ABCB1—Dexamethasone—psoriasis	0.00509	0.0235	CbGbCtD
Ivacaftor—CYP3A4—Hydrocortisone—psoriasis	0.0049	0.0226	CbGbCtD
Ivacaftor—CYP3A4—Prednisone—psoriasis	0.00488	0.0225	CbGbCtD
Ivacaftor—CYP3A4—Cyclosporine—psoriasis	0.00463	0.0214	CbGbCtD
Ivacaftor—ABCB1—Methotrexate—psoriasis	0.00409	0.0189	CbGbCtD
Ivacaftor—ORM1—vertebral column—psoriasis	0.00391	0.08	CbGeAlD
Ivacaftor—CYP3A4—Dexamethasone—psoriasis	0.00305	0.0141	CbGbCtD
Ivacaftor—Rash—Tazarotene—psoriasis	0.000263	0.00487	CcSEcCtD
Ivacaftor—Dermatitis—Tazarotene—psoriasis	0.000263	0.00487	CcSEcCtD
Ivacaftor—Tinnitus—Acitretin—psoriasis	0.000262	0.00485	CcSEcCtD
Ivacaftor—Gynaecomastia—Mycophenolate mofetil—psoriasis	0.00026	0.00481	CcSEcCtD
Ivacaftor—Mediastinal disorder—Fluocinolone Acetonide—psoriasis	0.000252	0.00468	CcSEcCtD
Ivacaftor—Infection—Methoxsalen—psoriasis	0.00025	0.00463	CcSEcCtD
Ivacaftor—Ear pain—Mycophenolate mofetil—psoriasis	0.000247	0.00458	CcSEcCtD
Ivacaftor—Infestation NOS—Hydroxyurea—psoriasis	0.000246	0.00455	CcSEcCtD
Ivacaftor—Infestation—Hydroxyurea—psoriasis	0.000246	0.00455	CcSEcCtD
Ivacaftor—Skin disorder—Methoxsalen—psoriasis	0.000244	0.00453	CcSEcCtD
Ivacaftor—Wheezing—Triamcinolone—psoriasis	0.000242	0.00448	CcSEcCtD
Ivacaftor—Breast disorder—Mycophenolic acid—psoriasis	0.000241	0.00447	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Mycophenolic acid—psoriasis	0.00024	0.00445	CcSEcCtD
Ivacaftor—Nasopharyngitis—Mycophenolic acid—psoriasis	0.000239	0.00442	CcSEcCtD
Ivacaftor—Myalgia—Calcitriol—psoriasis	0.000234	0.00434	CcSEcCtD
Ivacaftor—Rash—Clobetasol propionate—psoriasis	0.000223	0.00413	CcSEcCtD
Ivacaftor—Dermatitis—Clobetasol propionate—psoriasis	0.000223	0.00413	CcSEcCtD
Ivacaftor—Headache—Clobetasol propionate—psoriasis	0.000221	0.0041	CcSEcCtD
Ivacaftor—Hypoglycaemia—Cyclosporine—psoriasis	0.000221	0.0041	CcSEcCtD
Ivacaftor—Skin disorder—Calcitriol—psoriasis	0.000218	0.00404	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Methoxsalen—psoriasis	0.000217	0.00403	CcSEcCtD
Ivacaftor—Hypoglycaemia—Mycophenolate mofetil—psoriasis	0.000216	0.004	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Mycophenolic acid—psoriasis	0.000214	0.00397	CcSEcCtD
Ivacaftor—Dizziness—Beclomethasone—psoriasis	0.000213	0.00394	CcSEcCtD
Ivacaftor—Dizziness—Fluocinonide—psoriasis	0.000211	0.00391	CcSEcCtD
Ivacaftor—Myalgia—Acitretin—psoriasis	0.000208	0.00386	CcSEcCtD
Ivacaftor—Arthralgia—Acitretin—psoriasis	0.000208	0.00386	CcSEcCtD
Ivacaftor—Arthralgia—Fluocinolone Acetonide—psoriasis	0.000208	0.00385	CcSEcCtD
Ivacaftor—Infestation NOS—Mycophenolic acid—psoriasis	0.000206	0.00381	CcSEcCtD
Ivacaftor—Infestation—Mycophenolic acid—psoriasis	0.000206	0.00381	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Calcitriol—psoriasis	0.000204	0.00379	CcSEcCtD
Ivacaftor—Rash—Beclomethasone—psoriasis	0.000203	0.00376	CcSEcCtD
Ivacaftor—Dermatitis—Beclomethasone—psoriasis	0.000203	0.00376	CcSEcCtD
Ivacaftor—Headache—Beclomethasone—psoriasis	0.000202	0.00374	CcSEcCtD
Ivacaftor—Rash—Fluocinonide—psoriasis	0.000201	0.00373	CcSEcCtD
Ivacaftor—Dermatitis—Fluocinonide—psoriasis	0.000201	0.00372	CcSEcCtD
Ivacaftor—Headache—Fluocinonide—psoriasis	0.0002	0.0037	CcSEcCtD
Ivacaftor—Infection—Acitretin—psoriasis	0.000198	0.00367	CcSEcCtD
Ivacaftor—Infection—Fluocinolone Acetonide—psoriasis	0.000198	0.00366	CcSEcCtD
Ivacaftor—Breast disorder—Cyclosporine—psoriasis	0.000195	0.00362	CcSEcCtD
Ivacaftor—Nervous system disorder—Fluocinolone Acetonide—psoriasis	0.000195	0.00362	CcSEcCtD
Ivacaftor—Skin disorder—Acitretin—psoriasis	0.000194	0.00359	CcSEcCtD
Ivacaftor—Nausea—Beclomethasone—psoriasis	0.000191	0.00354	CcSEcCtD
Ivacaftor—Aspartate aminotransferase increased—Mycophenolate mofetil—psoriasis	0.00019	0.00352	CcSEcCtD
Ivacaftor—Rhinitis—Mycophenolic acid—psoriasis	0.000185	0.00343	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Calcitriol—psoriasis	0.000183	0.0034	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Acitretin—psoriasis	0.000182	0.00337	CcSEcCtD
Ivacaftor—Connective tissue disorder—Mycophenolic acid—psoriasis	0.000182	0.00336	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Fluocinolone Acetonide—psoriasis	0.000181	0.00336	CcSEcCtD
Ivacaftor—Abdominal pain—Calcitriol—psoriasis	0.000177	0.00329	CcSEcCtD
Ivacaftor—Hepatic enzyme increased—Methotrexate—psoriasis	0.000174	0.00322	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Cyclosporine—psoriasis	0.000174	0.00321	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Acitretin—psoriasis	0.000172	0.00319	CcSEcCtD
Ivacaftor—Tinnitus—Mycophenolic acid—psoriasis	0.000172	0.00319	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000172	0.00318	CcSEcCtD
Ivacaftor—Mediastinal disorder—Mycophenolic acid—psoriasis	0.000166	0.00308	CcSEcCtD
Ivacaftor—Infestation NOS—Cyclosporine—psoriasis	0.000166	0.00308	CcSEcCtD
Ivacaftor—Infestation—Cyclosporine—psoriasis	0.000166	0.00308	CcSEcCtD
Ivacaftor—Dizziness—Methoxsalen—psoriasis	0.000166	0.00308	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Acitretin—psoriasis	0.000163	0.00302	CcSEcCtD
Ivacaftor—Infestation—Mycophenolate mofetil—psoriasis	0.000162	0.00301	CcSEcCtD
Ivacaftor—Infestation NOS—Mycophenolate mofetil—psoriasis	0.000162	0.00301	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.000162	0.00301	CcSEcCtD
Ivacaftor—Rash—Methoxsalen—psoriasis	0.000159	0.00294	CcSEcCtD
Ivacaftor—Dermatitis—Methoxsalen—psoriasis	0.000159	0.00294	CcSEcCtD
Ivacaftor—Abdominal pain—Acitretin—psoriasis	0.000158	0.00292	CcSEcCtD
Ivacaftor—Headache—Methoxsalen—psoriasis	0.000158	0.00292	CcSEcCtD
Ivacaftor—Infection—Hydroxyurea—psoriasis	0.000156	0.00288	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Hydrocortisone—psoriasis	0.000154	0.00286	CcSEcCtD
Ivacaftor—Nervous system disorder—Hydroxyurea—psoriasis	0.000154	0.00285	CcSEcCtD
Ivacaftor—Diarrhoea—Calcitriol—psoriasis	0.000153	0.00284	CcSEcCtD
Ivacaftor—Skin disorder—Hydroxyurea—psoriasis	0.000152	0.00282	CcSEcCtD
Ivacaftor—Rhinitis—Cyclosporine—psoriasis	0.00015	0.00278	CcSEcCtD
Ivacaftor—Nausea—Methoxsalen—psoriasis	0.00015	0.00277	CcSEcCtD
Ivacaftor—Infestation NOS—Hydrocortisone—psoriasis	0.000148	0.00274	CcSEcCtD
Ivacaftor—Infestation—Hydrocortisone—psoriasis	0.000148	0.00274	CcSEcCtD
Ivacaftor—Gynaecomastia—Methotrexate—psoriasis	0.000147	0.00273	CcSEcCtD
Ivacaftor—Connective tissue disorder—Cyclosporine—psoriasis	0.000147	0.00272	CcSEcCtD
Ivacaftor—Rhinitis—Mycophenolate mofetil—psoriasis	0.000146	0.00271	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Triamcinolone—psoriasis	0.000145	0.00269	CcSEcCtD
Ivacaftor—Connective tissue disorder—Mycophenolate mofetil—psoriasis	0.000143	0.00265	CcSEcCtD
Ivacaftor—Rash—Calcitriol—psoriasis	0.000141	0.00262	CcSEcCtD
Ivacaftor—Dermatitis—Calcitriol—psoriasis	0.000141	0.00262	CcSEcCtD
Ivacaftor—Headache—Calcitriol—psoriasis	0.000141	0.0026	CcSEcCtD
Ivacaftor—Tinnitus—Cyclosporine—psoriasis	0.000139	0.00258	CcSEcCtD
Ivacaftor—Arthralgia—Mycophenolic acid—psoriasis	0.000137	0.00254	CcSEcCtD
Ivacaftor—Myalgia—Mycophenolic acid—psoriasis	0.000137	0.00254	CcSEcCtD
Ivacaftor—Diarrhoea—Acitretin—psoriasis	0.000137	0.00253	CcSEcCtD
Ivacaftor—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000136	0.00252	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000136	0.00252	CcSEcCtD
Ivacaftor—Tinnitus—Mycophenolate mofetil—psoriasis	0.000136	0.00252	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000135	0.00251	CcSEcCtD
Ivacaftor—Mediastinal disorder—Cyclosporine—psoriasis	0.000135	0.0025	CcSEcCtD
Ivacaftor—Nausea—Calcitriol—psoriasis	0.000133	0.00247	CcSEcCtD
Ivacaftor—Dizziness—Acitretin—psoriasis	0.000132	0.00245	CcSEcCtD
Ivacaftor—Dizziness—Fluocinolone Acetonide—psoriasis	0.000132	0.00244	CcSEcCtD
Ivacaftor—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.000131	0.00243	CcSEcCtD
Ivacaftor—Connective tissue disorder—Hydrocortisone—psoriasis	0.000131	0.00242	CcSEcCtD
Ivacaftor—Infection—Mycophenolic acid—psoriasis	0.00013	0.00242	CcSEcCtD
Ivacaftor—Nervous system disorder—Mycophenolic acid—psoriasis	0.000129	0.00238	CcSEcCtD
Ivacaftor—Skin disorder—Mycophenolic acid—psoriasis	0.000127	0.00236	CcSEcCtD
Ivacaftor—Rash—Acitretin—psoriasis	0.000126	0.00233	CcSEcCtD
Ivacaftor—Dermatitis—Acitretin—psoriasis	0.000126	0.00233	CcSEcCtD
Ivacaftor—Rash—Fluocinolone Acetonide—psoriasis	0.000125	0.00232	CcSEcCtD
Ivacaftor—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000125	0.00232	CcSEcCtD
Ivacaftor—Rhinitis—Triamcinolone—psoriasis	0.000125	0.00232	CcSEcCtD
Ivacaftor—Headache—Acitretin—psoriasis	0.000125	0.00232	CcSEcCtD
Ivacaftor—Headache—Fluocinolone Acetonide—psoriasis	0.000125	0.00231	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.00012	0.00222	CcSEcCtD
Ivacaftor—Nausea—Acitretin—psoriasis	0.000119	0.0022	CcSEcCtD
Ivacaftor—Nausea—Fluocinolone Acetonide—psoriasis	0.000118	0.00219	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000113	0.0021	CcSEcCtD
Ivacaftor—Myalgia—Cyclosporine—psoriasis	0.000111	0.00205	CcSEcCtD
Ivacaftor—Arthralgia—Cyclosporine—psoriasis	0.000111	0.00205	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.00011	0.00204	CcSEcCtD
Ivacaftor—Arthralgia—Mycophenolate mofetil—psoriasis	0.000108	0.002	CcSEcCtD
Ivacaftor—Myalgia—Mycophenolate mofetil—psoriasis	0.000108	0.002	CcSEcCtD
Ivacaftor—Breast disorder—Methotrexate—psoriasis	0.000108	0.002	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000107	0.00199	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000107	0.00199	CcSEcCtD
Ivacaftor—Diarrhoea—Hydroxyurea—psoriasis	0.000107	0.00199	CcSEcCtD
Ivacaftor—Infection—Cyclosporine—psoriasis	0.000105	0.00195	CcSEcCtD
Ivacaftor—Nervous system disorder—Cyclosporine—psoriasis	0.000104	0.00193	CcSEcCtD
Ivacaftor—Abdominal pain—Mycophenolic acid—psoriasis	0.000104	0.00192	CcSEcCtD
Ivacaftor—Dizziness—Hydroxyurea—psoriasis	0.000104	0.00192	CcSEcCtD
Ivacaftor—Skin disorder—Cyclosporine—psoriasis	0.000103	0.00191	CcSEcCtD
Ivacaftor—Infection—Mycophenolate mofetil—psoriasis	0.000103	0.00191	CcSEcCtD
Ivacaftor—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000102	0.00188	CcSEcCtD
Ivacaftor—Skin disorder—Mycophenolate mofetil—psoriasis	0.000101	0.00186	CcSEcCtD
Ivacaftor—Rash—Hydroxyurea—psoriasis	9.88e-05	0.00183	CcSEcCtD
Ivacaftor—Dermatitis—Hydroxyurea—psoriasis	9.87e-05	0.00183	CcSEcCtD
Ivacaftor—Myalgia—Hydrocortisone—psoriasis	9.84e-05	0.00182	CcSEcCtD
Ivacaftor—Headache—Hydroxyurea—psoriasis	9.82e-05	0.00182	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	9.77e-05	0.00181	CcSEcCtD
Ivacaftor—Connective tissue disorder—Prednisone—psoriasis	9.71e-05	0.0018	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Cyclosporine—psoriasis	9.67e-05	0.00179	CcSEcCtD
Ivacaftor—Upper respiratory tract infection—Methotrexate—psoriasis	9.59e-05	0.00178	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	9.44e-05	0.00175	CcSEcCtD
Ivacaftor—Infection—Hydrocortisone—psoriasis	9.37e-05	0.00174	CcSEcCtD
Ivacaftor—Nausea—Hydroxyurea—psoriasis	9.31e-05	0.00172	CcSEcCtD
Ivacaftor—Myalgia—Triamcinolone—psoriasis	9.27e-05	0.00172	CcSEcCtD
Ivacaftor—Nervous system disorder—Hydrocortisone—psoriasis	9.25e-05	0.00171	CcSEcCtD
Ivacaftor—Infestation NOS—Methotrexate—psoriasis	9.2e-05	0.0017	CcSEcCtD
Ivacaftor—Infestation—Methotrexate—psoriasis	9.2e-05	0.0017	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Cyclosporine—psoriasis	9.17e-05	0.0017	CcSEcCtD
Ivacaftor—Skin disorder—Hydrocortisone—psoriasis	9.16e-05	0.0017	CcSEcCtD
Ivacaftor—Diarrhoea—Mycophenolic acid—psoriasis	8.98e-05	0.00166	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	8.94e-05	0.00166	CcSEcCtD
Ivacaftor—Infection—Triamcinolone—psoriasis	8.83e-05	0.00164	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Cyclosporine—psoriasis	8.68e-05	0.00161	CcSEcCtD
Ivacaftor—Dizziness—Mycophenolic acid—psoriasis	8.68e-05	0.00161	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Hydrocortisone—psoriasis	8.6e-05	0.00159	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	8.47e-05	0.00157	CcSEcCtD
Ivacaftor—Myalgia—Dexamethasone—psoriasis	8.41e-05	0.00156	CcSEcCtD
Ivacaftor—Myalgia—Betamethasone—psoriasis	8.41e-05	0.00156	CcSEcCtD
Ivacaftor—Abdominal pain—Cyclosporine—psoriasis	8.39e-05	0.00155	CcSEcCtD
Ivacaftor—Rash—Mycophenolic acid—psoriasis	8.27e-05	0.00153	CcSEcCtD
Ivacaftor—Dermatitis—Mycophenolic acid—psoriasis	8.27e-05	0.00153	CcSEcCtD
Ivacaftor—Headache—Mycophenolic acid—psoriasis	8.22e-05	0.00152	CcSEcCtD
Ivacaftor—Abdominal pain—Mycophenolate mofetil—psoriasis	8.19e-05	0.00152	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Hydrocortisone—psoriasis	8.15e-05	0.00151	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Triamcinolone—psoriasis	8.09e-05	0.0015	CcSEcCtD
Ivacaftor—Infection—Dexamethasone—psoriasis	8.01e-05	0.00148	CcSEcCtD
Ivacaftor—Infection—Betamethasone—psoriasis	8.01e-05	0.00148	CcSEcCtD
Ivacaftor—Nervous system disorder—Betamethasone—psoriasis	7.91e-05	0.00146	CcSEcCtD
Ivacaftor—Nervous system disorder—Dexamethasone—psoriasis	7.91e-05	0.00146	CcSEcCtD
Ivacaftor—Nausea—Mycophenolic acid—psoriasis	7.8e-05	0.00144	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Hydrocortisone—psoriasis	7.72e-05	0.00143	CcSEcCtD
Ivacaftor—Tinnitus—Methotrexate—psoriasis	7.7e-05	0.00143	CcSEcCtD
Ivacaftor—Abdominal pain—Hydrocortisone—psoriasis	7.46e-05	0.00138	CcSEcCtD
Ivacaftor—Mediastinal disorder—Methotrexate—psoriasis	7.44e-05	0.00138	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Dexamethasone—psoriasis	7.34e-05	0.00136	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Betamethasone—psoriasis	7.34e-05	0.00136	CcSEcCtD
Ivacaftor—Myalgia—Prednisone—psoriasis	7.32e-05	0.00136	CcSEcCtD
Ivacaftor—Arthralgia—Prednisone—psoriasis	7.32e-05	0.00136	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	7.27e-05	0.00135	CcSEcCtD
Ivacaftor—Diarrhoea—Cyclosporine—psoriasis	7.26e-05	0.00135	CcSEcCtD
Ivacaftor—Diarrhoea—Mycophenolate mofetil—psoriasis	7.09e-05	0.00131	CcSEcCtD
Ivacaftor—Dizziness—Cyclosporine—psoriasis	7.02e-05	0.0013	CcSEcCtD
Ivacaftor—Infection—Prednisone—psoriasis	6.97e-05	0.00129	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Betamethasone—psoriasis	6.96e-05	0.00129	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Dexamethasone—psoriasis	6.96e-05	0.00129	CcSEcCtD
Ivacaftor—Nervous system disorder—Prednisone—psoriasis	6.88e-05	0.00128	CcSEcCtD
Ivacaftor—Dizziness—Mycophenolate mofetil—psoriasis	6.85e-05	0.00127	CcSEcCtD
Ivacaftor—Skin disorder—Prednisone—psoriasis	6.82e-05	0.00126	CcSEcCtD
Ivacaftor—Rash—Cyclosporine—psoriasis	6.69e-05	0.00124	CcSEcCtD
Ivacaftor—Dermatitis—Cyclosporine—psoriasis	6.69e-05	0.00124	CcSEcCtD
Ivacaftor—Headache—Cyclosporine—psoriasis	6.65e-05	0.00123	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Betamethasone—psoriasis	6.59e-05	0.00122	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Dexamethasone—psoriasis	6.59e-05	0.00122	CcSEcCtD
Ivacaftor—Rash—Mycophenolate mofetil—psoriasis	6.53e-05	0.00121	CcSEcCtD
Ivacaftor—Dermatitis—Mycophenolate mofetil—psoriasis	6.52e-05	0.00121	CcSEcCtD
Ivacaftor—Headache—Mycophenolate mofetil—psoriasis	6.49e-05	0.0012	CcSEcCtD
Ivacaftor—Diarrhoea—Hydrocortisone—psoriasis	6.46e-05	0.0012	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Prednisone—psoriasis	6.4e-05	0.00118	CcSEcCtD
Ivacaftor—Dizziness—Prednisolone—psoriasis	6.39e-05	0.00118	CcSEcCtD
Ivacaftor—Abdominal pain—Betamethasone—psoriasis	6.37e-05	0.00118	CcSEcCtD
Ivacaftor—Abdominal pain—Dexamethasone—psoriasis	6.37e-05	0.00118	CcSEcCtD
Ivacaftor—Nausea—Cyclosporine—psoriasis	6.31e-05	0.00117	CcSEcCtD
Ivacaftor—Dizziness—Hydrocortisone—psoriasis	6.24e-05	0.00116	CcSEcCtD
Ivacaftor—Nausea—Mycophenolate mofetil—psoriasis	6.15e-05	0.00114	CcSEcCtD
Ivacaftor—Arthralgia—Methotrexate—psoriasis	6.12e-05	0.00113	CcSEcCtD
Ivacaftor—Myalgia—Methotrexate—psoriasis	6.12e-05	0.00113	CcSEcCtD
Ivacaftor—Rash—Prednisolone—psoriasis	6.09e-05	0.00113	CcSEcCtD
Ivacaftor—Dermatitis—Prednisolone—psoriasis	6.09e-05	0.00113	CcSEcCtD
Ivacaftor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.08e-05	0.00113	CcSEcCtD
Ivacaftor—Headache—Prednisolone—psoriasis	6.05e-05	0.00112	CcSEcCtD
Ivacaftor—Rash—Hydrocortisone—psoriasis	5.95e-05	0.0011	CcSEcCtD
Ivacaftor—Dermatitis—Hydrocortisone—psoriasis	5.94e-05	0.0011	CcSEcCtD
Ivacaftor—Headache—Hydrocortisone—psoriasis	5.91e-05	0.0011	CcSEcCtD
Ivacaftor—Dizziness—Triamcinolone—psoriasis	5.87e-05	0.00109	CcSEcCtD
Ivacaftor—Infection—Methotrexate—psoriasis	5.83e-05	0.00108	CcSEcCtD
Ivacaftor—Nervous system disorder—Methotrexate—psoriasis	5.75e-05	0.00107	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Prednisone—psoriasis	5.74e-05	0.00106	CcSEcCtD
Ivacaftor—Nausea—Prednisolone—psoriasis	5.74e-05	0.00106	CcSEcCtD
Ivacaftor—Skin disorder—Methotrexate—psoriasis	5.7e-05	0.00106	CcSEcCtD
Ivacaftor—Nausea—Hydrocortisone—psoriasis	5.6e-05	0.00104	CcSEcCtD
Ivacaftor—Rash—Triamcinolone—psoriasis	5.6e-05	0.00104	CcSEcCtD
Ivacaftor—Dermatitis—Triamcinolone—psoriasis	5.6e-05	0.00104	CcSEcCtD
Ivacaftor—Headache—Triamcinolone—psoriasis	5.57e-05	0.00103	CcSEcCtD
Ivacaftor—Abdominal pain—Prednisone—psoriasis	5.55e-05	0.00103	CcSEcCtD
Ivacaftor—Diarrhoea—Betamethasone—psoriasis	5.52e-05	0.00102	CcSEcCtD
Ivacaftor—Diarrhoea—Dexamethasone—psoriasis	5.52e-05	0.00102	CcSEcCtD
Ivacaftor—Musculoskeletal discomfort—Methotrexate—psoriasis	5.35e-05	0.00099	CcSEcCtD
Ivacaftor—Dizziness—Dexamethasone—psoriasis	5.33e-05	0.000988	CcSEcCtD
Ivacaftor—Dizziness—Betamethasone—psoriasis	5.33e-05	0.000988	CcSEcCtD
Ivacaftor—Nausea—Triamcinolone—psoriasis	5.28e-05	0.000978	CcSEcCtD
Ivacaftor—Rash—Dexamethasone—psoriasis	5.08e-05	0.000942	CcSEcCtD
Ivacaftor—Rash—Betamethasone—psoriasis	5.08e-05	0.000942	CcSEcCtD
Ivacaftor—Dermatitis—Betamethasone—psoriasis	5.08e-05	0.000941	CcSEcCtD
Ivacaftor—Dermatitis—Dexamethasone—psoriasis	5.08e-05	0.000941	CcSEcCtD
Ivacaftor—Gastrointestinal disorder—Methotrexate—psoriasis	5.07e-05	0.000938	CcSEcCtD
Ivacaftor—Headache—Dexamethasone—psoriasis	5.05e-05	0.000936	CcSEcCtD
Ivacaftor—Headache—Betamethasone—psoriasis	5.05e-05	0.000936	CcSEcCtD
Ivacaftor—Diarrhoea—Prednisone—psoriasis	4.8e-05	0.00089	CcSEcCtD
Ivacaftor—Gastrointestinal pain—Methotrexate—psoriasis	4.8e-05	0.000889	CcSEcCtD
Ivacaftor—Nausea—Betamethasone—psoriasis	4.79e-05	0.000887	CcSEcCtD
Ivacaftor—Nausea—Dexamethasone—psoriasis	4.79e-05	0.000887	CcSEcCtD
Ivacaftor—Dizziness—Prednisone—psoriasis	4.64e-05	0.00086	CcSEcCtD
Ivacaftor—Abdominal pain—Methotrexate—psoriasis	4.64e-05	0.000859	CcSEcCtD
Ivacaftor—Rash—Prednisone—psoriasis	4.43e-05	0.00082	CcSEcCtD
Ivacaftor—Dermatitis—Prednisone—psoriasis	4.42e-05	0.000819	CcSEcCtD
Ivacaftor—Headache—Prednisone—psoriasis	4.4e-05	0.000815	CcSEcCtD
Ivacaftor—Nausea—Prednisone—psoriasis	4.17e-05	0.000773	CcSEcCtD
Ivacaftor—Diarrhoea—Methotrexate—psoriasis	4.01e-05	0.000744	CcSEcCtD
Ivacaftor—Dizziness—Methotrexate—psoriasis	3.88e-05	0.000719	CcSEcCtD
Ivacaftor—Rash—Methotrexate—psoriasis	3.7e-05	0.000685	CcSEcCtD
Ivacaftor—Dermatitis—Methotrexate—psoriasis	3.7e-05	0.000685	CcSEcCtD
Ivacaftor—Headache—Methotrexate—psoriasis	3.68e-05	0.000681	CcSEcCtD
Ivacaftor—Nausea—Methotrexate—psoriasis	3.48e-05	0.000646	CcSEcCtD
